Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02799394
Other study ID # N- 20140100-1
Secondary ID
Status Completed
Phase N/A
First received June 10, 2016
Last updated January 27, 2018
Start date June 2016
Est. completion date December 2017

Study information

Verified date January 2018
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of activity modification, exercises and a gradual return to sport in adolescents (age 10-14) with Osgood Schlatter disease. The primary outcome is self-reported recovery on a 7-point Likert scale at 3 months. Secondary endpoints include 4 and 8 weeks and 6 and 12 months after inclusion into the project. The adolescents will be recruited from primary schools, general practitioners and through online advertising on Facebook.


Recruitment information / eligibility

Status Completed
Enrollment 51
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender All
Age group 10 Years to 14 Years
Eligibility Inclusion Criteria:

- 10-14 years of age

- Pain at tuberositas patellae during two or more of the following activities: Sitting with a bent knee, squatting, running, jumping or stair ambulation

- Pain during palpation of tuberositas patellae

- Knee pain for 6 weeks or more

Exclusion Criteria:

- Other knee conditions that may manifest as anterior knee pain (Patellofemoral pain, iliotibial band syndrome, sinding-larson-johanson disease).

- Previous surgery

- Pain from the hip or back that interferes with activities of daily living.

- Habitual patella luxations

- Clinical suspicion of meniscal lesion

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Activity modification, exercises and gradual return to sport


Locations

Country Name City State
Denmark Aalborg Universitetshospital Aalborg The North Denmark Region
Denmark Hvidovre-Amager Hospital Hvidovre

Sponsors (1)

Lead Sponsor Collaborator
Aalborg University

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Self-reported recovery on a 7-point Likert scale 3 months
Secondary Self-reported recovery on a 7-point Likert scale 4 and 8 weeks + 6 and 12 months after inclusion.
Secondary Self-report questionnaire "Knee Injury and Osteoarthritis Outcome Score" 4, 8 and 12 weeks + 6 and 12 months after inclusion.
Secondary Isometric hip and knee extension strength assessed using a strap-mounted dynamometer 4, 8 and 12 weeks after inclusion.
Secondary Pressure pain thresholds at tuberositas patella, center of patella and lateral elbow assessed by a hand held pressure algometer. 4, 8 and 12 weeks after inclusion.
Secondary Thigh circumference measured using tape measure. 4, 8 and 12 weeks after inclusion.
Secondary Vertical jump for height [calculated as the difference between reach height and maximal jump height. This will be measured using a ruler] 4, 8 and 12 weeks after inclusion.
Secondary Single leg jump for distance (defined as the maximal length the subject can jump on one leg. Measured using a ruler). 4, 8 and 12 weeks after inclusion.
Secondary Flexibility of the hamstrings and quadriceps [measured using goniometer]. 4, 8 and 12 weeks after inclusion.
See also
  Status Clinical Trial Phase
Completed NCT02824172 - Treatment of the Osgood Schlatter N/A